Blood pressure control with valsartan and hydrochlorothiazide in clinical practice: the MACHT Observational Study

Blood Pressure. Supplement
Markus AbtsMarcos Lataster

Abstract

Reduction of blood pressure (BP) in hypertensive patients reduces cardiovascular risk, with substantial reductions in death from cardiovascular disease and all-cause mortality. This observational study assessed BP reduction in 17,242 patients with uncontrolled hypertension (mean baseline BP 165.4/95.8 mmHg) treated in clinical practice with a combination of valsartan 160 mg and hydrochlorothiazide (HCTZ) 12.5 mg by non-hospital specialists and general practitioners. BP was recorded at baseline and at 1 and 3 months with efficacy assessed as BP change from baseline at last timepoint. Mean systolic and diastolic BP reductions of -27.0 mmHg and -13.7 mmHg were achieved overall, with greater reductions in previously untreated patients or in those with a higher baseline BP. Response rates were high overall (78%), and in both formerly antihypertensive naive patients (87%) and in pre-treated patients (76%). The combination of valsartan and HCTZ was well tolerated with a discontinuation rate due to adverse events of <0.4%. In routine clinical practice, valsartan plus HCTZ is effective at reducing BP with high response rates despite patients having previously uncontrolled hypertension, and regardless of individual risk status. The low a...Continue Reading

References

Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jun 5, 2003·Journal of Hypertension·UNKNOWN European Society of Hypertension-European Society of Cardiology Guidelines Committee

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.